title: Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization.
abstract: Pharmaceutical compounds are molecular solids that frequently exhibit polymorphism of crystal form. One high profile case of polymorphism was ritonavir, a peptidomimetic drug used to treat HIV-1 infection and introduced in 1996. In 1998, a lower energy, more stable polymorph (form II) appeared, causing slowed dissolution of the marketed dosage form and compromising the oral bioavailability of the drug. This event forced the removal of the oral capsule formulation from the market. We have carried out high-throughput crystallization experiments to comprehensively explore ritonavir form diversity. A total of five forms were found: both known forms and three previously unknown forms. The novel forms include a metastable polymorph, a hydrate phase, and a formamide solvate. The solvate was converted to form I via the hydrate phase by using a simple washing procedure, providing an unusual route to prepare the form I "disappearing polymorph" [Dunitz, J. D. & Bernstein, J. (1995) Acc. Chem. Res. 28, 193-200]. Crystals of form I prepared by using this method retained the small needle morphology of the solvate and thus offer a potential strategy for particle size and morphology control.
authors.affiliation: TransForm Pharmaceuticals, Inc., 29 Hartwell Avenue, Lexington, MA 02421, USA. morissette@transformpharma.com
authors.forename: Sherry L
authors.initials: SL
authors.lastname: Morissette
authors.forename: Stephen
authors.initials: S
authors.lastname: Soukasene
authors.forename: Douglas
authors.initials: D
authors.lastname: Levinson
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Cima
authors.forename: Orn
authors.initials: O
authors.lastname: Almarsson
mesh_terms: D018360:Crystallography, X-Ray; D017320:HIV Protease Inhibitors / Q000737:chemistry*; D010455:Peptides / Q000737:chemistry*; D019438:Ritonavir / Q000737:chemistry*; D013059:Spectrum Analysis, Raman; D013696:Temperature
chemical_list: D017320:HIV Protease Inhibitors; D010455:Peptides; D019438:Ritonavir